Here are the top performing biotechs in 2025 as measured from intraday low to intraday high excluding pre-market activity. This does not include stocks that were acquired as I am to lazy right now to write that query so this suffers from survivor’s bias.
I have premarket data but I am ignoring it here. So the gains may be actually higher for some.
Here are the Gravity Analytica EM Charts from the date they reached the low.
Abivax returned 1941% on the year, 3000% from the low. We owned this but because it did not stay in the channel very long, we did not own very much.
Virios Therapeutics returned 1400% from the low. This was an RS + name change play that unfolded in January and we don’t have a chart from the date of the low because of the CIK collision. Here is the chart closed to the spike under the new company name Dogwood Therapeutics. As you can see it was a green event + FST setup.
Relmada Therapeutics made a max return of 2000%. This was an event + FST setup below the channel.
NovaBay Pharmaceuticals returned 1300%.
Terns Pharmaceuticals returned 2500%. We played this in 2022 but missed it this past year because we had not fully re-entered the market yet.
Now for the big winners.
Spruce Biosciences which returned 5500% from a split adjusted $4 to $200. I even explicitly stated what was about to happen before it happened. We owned this.
Pheton Holdings which returned 7500% in an FST window. This was completely liquidity restricted and you likely couldn’t have bought shares.
Another event + FST setup was Mink Therapeutics which returned 16000% in July. I am ashamed to say I think I sold this for 40%…
An Klotho Neurosciences which was in an FST and returned a paltry 3500% but has to win the most Sci-Fi name award.
As you can see the code found every one of them.
If you like our risk/event charts they are available in chat via subscription. This subscription fee covers the cost of running all this code. Amazon Web services and data plans are not cheap.
As always, if you think there are spelling errors update your dictionary to the latest version. Happy speculation!
— AJ
Event Horizon Tools
DISCLAIMER: DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Our website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Past performance is not indicative of future results. The material contained on this page is intended for informational purposes only. GravityAnalytica.com is wholly-owned by Gravity Analytica, LLC. Our website is not an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content of our website and/or newsletter is not provided to any individual with a view toward their individual circumstances. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on our website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. We reserve the right to buy or sell shares of any company mentioned on our website or in our newsletter at any time. We encourage you to invest carefully and read investment information available at the websites of the SEC at http://www.sec.gov and FINRA at http://www.finra.org.
The company or individuals affiliated may hold positions or may enter into, or exit, positions on any equities at any time. This website and materials found on this website, or in any communication, are meant for individuals of eighteen (18) years of age or older and are not suitable for younger audiences. Materials and information provided on this website and in any communications with or from Gravity Analytica LLC, it’s employees or affiliates, are for personal education use by subscribers and may be not be used in any regard in competition with this website or any other product or service offered by Gravity Analytica LLC. Past results do not predict future returns. IF YOU DO NOT AGREE WITH THE TERMS OF THIS DISCLAIMER, PLEASE EXIT THIS SITE IMMEDIATELY. PLEASE BE ADVISED THAT YOUR CONTINUED USE OF THIS SITE OR THE INFORMATION PROVIDED HEREIN SHALL INDICATE YOUR CONSENT AND AGREEMENT TO THESE TERMS.
